Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abrazo is a medical technology company focused on developing a next-generation physiological heart pump for the treatment of advanced heart failure. The company's technology is designed to provide mechanical circulatory support that is more physiologically compatible and less invasive than existing ventricular assist devices. Founded by a leadership team with deep expertise in the mechanical circulatory support industry, Abrazo aims to redefine the standard of care for patients requiring long-term cardiac support. The company is currently in the pre-clinical development phase, working toward clinical trials to validate its innovative approach to heart failure management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abrazo Heart.